GLP1 Agonist (APC Approved)
Date: 01 February 2020 to 01 January 2099
-
Due for review31 October 2026
-
TypeShared Care Guidelines
-
Clinical support group
- Endocrine and Diabetes
-
Drug
-
Traffic LightAmber (G)
-
Conditions and indicators
Do you want to add this to your CPD record?
Did you find this page helpful?